CClinicalTrials.gg
Not yet recruitingNCT07683494Updated Jul 6, 2026

Kinesiotape Versus Compression Stockings on Pregnant Leg Cramps and Sleep Quality

An interventional study of Control group and Kinesiotape group in Leg Cramps in Pregnant Women, sponsored by Kafrelsheikh University. Not yet recruiting at 2 sites in Egypt. Open to female participants aged 25 Weeks to 35 Weeks. Per ClinicalTrials.gov, last updated 2026-07-06.

Sponsored by Kafrelsheikh University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
25 Weeks to 35 Weeks
Sex
Female
01

Study summary

Kinesiotape versus compression stockings on pregnant leg cramps and sleep quality

Read the detailed description

Effect of kinesiotape versus compression stockings on leg cramps and sleep quality in pregnant women A Randomized controlled trial

02

Conditions studied

  • Leg Cramps in Pregnant Women

Keywords

  • Leg cramps in pregnant women
  • Kinesiotape
03

In context

Lead sponsor

Kafrelsheikh University is the lead sponsor of 285 studies on the registry; 110 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Weeks to 35 Weeks
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • -Pregnant female suffering from calf cramps. 2-Their ages range from 25to 35 years. 3-Their body mass index ranges from 25 to 29.9kg/m2. 4-Pregnant female in the second or third trimester.

Exclusion criteria

Exclusion Criteria:

  • Skin abnormalities [malignancy or burn in the treated area]. 2-History of previous back surgery. 3-Present of any neuromuscular disease [like multiple sclerosis]. 4-Sensory disturbances. 5-Evidence of previous vertebral fractures or spinal structural abnormalities. 6-Women who have eclampsia or pre-eclampsia. 7-History of edema, thrombosis, venous thrombosis.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Control

    Control group receive instructions about dealing with leg cramps at bedtime

    Other: Control group

  • Experimental
    Kinesiotape group

    Application of kinesiology tape to the lower leg muscles for 48 hours, applied twice a week for 4 weeks, in addition to standard instructions for managing leg cramps at bedtime

    Other: Control group · Other: Kinesiotape group

  • Experimental
    Compression stockings group

    Use of graduated compression stockings worn daily for a period of 4 weeks, in addition to standard instructions for managing leg cramps at bedtime.

    Other: Control group · Other: Compression stockings group

Interventions

  • OtherControl group

    Receive instructions about dealing with leg cramps at bedtime as sustained stretch,massage and optimal sleeping position

  • OtherKinesiotape group

    Application of kinesiology tape to the lower leg muscles for 48 hours, applied twice a week for 4 weeks, in addition to standard instructions for managing leg cramps at bedtime

  • OtherCompression stockings group

    Use of graduated compression stockings worn daily for a period of 4 weeks, in addition to standard instructions for managing leg cramps at bedtime.

06

What researchers measure

Primary outcomes

  1. Muscle cramp characteristics measured using The Cramp Questionnaire

    Change in leg cramp frequency assessed using the Leg Cramp Questionnaire. Higher scores indicate greater cramp frequency.

    Time frame: Baseline and after4weeks

  2. Leg cramp pain intensty measured using visual analogue scale

    Pain intensity using visual analogue scale 0=no pain,10=wirst pain

    Time frame: Baseline and after4weeks

Secondary outcomes

  1. Sleep quality measured using sleep quality index

    Sleep quality assesed using the Pittsburgh sleep quality index score range 0-21 higher score means poor sleep quality

    Time frame: Baseline and after4weeks

  2. Quality of life measured using 12-item short form health survey

    Health related quality of life assesed using the SF-12questionnaire.higher score indicates better health status

    Time frame: Baseline and after4weeks

07

Study locations

2 sites
  • Elnasria medical centre
    Samannoud, Elgharbia, Egypt
  • Elnasria medical centre
    Samanonud, Elgharbia, Egypt
08

References and documents

Individual participant data

Plan to share: No — Individual participants data will not be shared

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07683494
Lead sponsor
Kafrelsheikh University
Responsible party
Noha fathy abdelhamid khalifa (Senior of physical therapy at elnasria medical centre -samnoud, Kafrelsheikh University) — Principal investigator
First posted
Jul 6, 2026
Start date
Jul 2026 (estimated)
Primary completion
Aug 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jul 6, 2026

Study contacts

Noha Fathy Khalifa, Bachelor
Contact
nohapt44@gmail.com
0201558281224
Noha Fathy khalifa, Bachelor
principal investigator · Faculty of physical therapy kafrelsheikh university

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion